MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

计划入组 50 人 · 首次发布于 2023 年 7 月 10 日

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome

计划入组 7 人 · 首次发布于 2019 年 9 月 26 日

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

计划入组 796 人 · 首次发布于 2025 年 12 月 12 日

opioid withdrawal symptom therapeutics

Foreskin keratinocyte (neonatal)(Gintuit)

Foreskin fibroblast (neonatal)(Gintuit)

HOSPITAL MATERNO NEONATAL

Argentina

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

Lofexidine Trial Launched for Neonatal Opioid Withdrawal Syndrome

Spark Biomedical Completes Enrollment in Two Pivotal Neurostimulation Trials for Opioid Use Disorder and Neonatal Withdrawal

Symptom-Based Opioid Dosing Reduces Hospital Stay for Newborns with Withdrawal Syndrome